Key Takeaways & Executive Findings
- •• Novel urethral microenvironment-adaptive hydrogel scaffolds, such as gelatin methacryloyl phenylboronic acid/cis-diol crosslinked hydrogels and alginate-nanohydroxyapatite-polysilane-silicon quantum dot composites, promote scarless repair and angiogenesis. • Functionalized composites of decellularized extracellular matrix with synthetic/natural materials preserve bioactivity while improving mechanical properties and repair outcomes. • Cell-free and intelligent scaffold strategies, such as exosome-loaded or engineered extracellular vesicle hydrogels, avoid risks of live cell transplantation and enable precise regulation of the repair microenvironment. • Current challenges include mechanical mismatch with dynamic urethral environment, difficulty in coordinating degradation with tissue regeneration, and barriers to clinical translation and standardized production.
Abstract
BACKGROUND: In recent years, hydrogel scaffolds, as important carriers in the field of tissue engineering, have made significant progress in their application in urethral repair and reconstruction. OBJECTIVE: To systematically review the design strategies of urethral tissue engineering scaffolds, the functional modification of hydrogel scaffolds, and their application progress in urethral repair, and to explore the future development directions and clinical transformation challenges of hydrogel scaffolds. METHODS: The CNKI and PubMed databases were searched using Chinese and English keywords "hydrogel, tissue engineering scaffold, urethral tissue engineering, urethral repair, urethral reconstruction." Based on the inclusion criteria, 69 articles were finally selected for inductive analysis. RESULTS AND CONCLUSION: In urethral tissue engineering, urethral scaffolds should not only possess basic characteristics such as biocompatibility but also exhibit unique properties that adapt to the structure of the urethra and the urinary environment. Hydrogel scaffolds can be classified into natural hydrogel scaffolds (commonly protein-based, polysaccharide-based, DNA-based, and extracellular matrix-based) and synthetic polymer hydrogel scaffolds (commonly polyvinyl alcohol, polyacrylic acid, acrylate-based). Crosslinking methods mainly include physical and chemical crosslinking, and preparation methods include in situ gelation, freeze-drying, electrospinning, and 3D bioprinting. To avoid the drawbacks of single materials, composite hydrogel scaffolds are often used in urethral tissue engineering, such as composite scaffolds adapted to the urethral microenvironment, composite scaffolds utilizing decellularized extracellular matrix, multilayer composite scaffolds loaded with stem cells, and non-stem cell-based hydrogel scaffolds. With the development of tissue engineering and regenerative medicine, future hydrogel scaffolds should be designed with intelligent, engineered, and cell-free strategies, while considering current clinical translation barriers and proposing comprehensive solutions.
1. Introduction
The urethra, as an internal structure of the human body, is a conduit connecting the bladder to the exterior. Its core function is to transport urine, and in males, it also serves to transport semen during reproduction. In urology, various pathological factors can lead to urethral injury, adversely affecting patients' quality of life. Among these, congenital urethral defects (e.g., hypospadias) and acquired urethral abnormalities (e.g., urethral stricture) are the most common [1]. Urethroplasty is the primary surgical treatment for hypospadias and urethral stricture, but postoperative complications are frequent, including fistulas, strictures, and dehiscence or recurrence after aponeurotic repair [1]. The continuous advancement of tissue engineering offers new possibilities for urethral repair and reconstruction, potentially overcoming the limitations of current treatments and improving surgical outcomes [2].
Tissue engineering is an interdisciplinary field that integrates biology, materials science, medicine, and engineering to provide novel techniques and therapeutic strategies for tissue and organ regeneration [2]. The core of tissue engineering is the construction of a three-dimensional complex composed of cells and biomaterials. These biomaterials not only promote the ingrowth of surrounding tissues and cells but also serve as temporary scaffolds for cell adhesion, proliferation, and differentiation. A key aspect is the development of biomimetic scaffolds to facilitate tissue regeneration, and hydrogels, with properties highly similar to the natural extracellular matrix, have become ideal carriers for this purpose [3].
Hydrogels are water-swollen three-dimensional polymer networks with tunable physicochemical properties that can be tailored to specific requirements. As promising materials, hydrogels are widely used in biomedical fields, ranging from physiological and pathological mechanism studies to tissue regeneration and disease treatment [4]. The core structure of hydrogels is a crosslinked polymer network [5], characterized by high hydrophilicity, high water content (up to 99.5%), extensibility, and biocompatibility close to living tissues [6-7]. These attributes make hydrogels ideal candidate materials for urethral tissue engineering scaffolds. This review aims to summarize the research achievements of hydrogel scaffolds in tissue-engineered urethral repair and reconstruction, and to discuss future development directions and challenges in clinical translation.
Loading authentic research manuscript (Pages 1–5)...
Qiu Jiajing, Huang Liqu (2026). Hydrogel scaffolds in tissue engineering for urethral repair and reconstruction. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21594
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are the main types of hydrogel scaffolds used in urethral tissue engineering?
Hydrogel scaffolds are classified into natural (e.g., protein-based, polysaccharide-based, DNA-based, extracellular matrix-based) and synthetic polymer (e.g., polyvinyl alcohol, polyacrylic acid, acrylate-based) types. Composite hydrogels combining multiple materials are often used to overcome individual limitations.
What are the key properties required for urethral scaffolds?
Urethral scaffolds must possess biocompatibility, appropriate mechanical strength to withstand the dynamic urethral environment, controlled degradation matching tissue regeneration, and the ability to support cell adhesion, proliferation, and differentiation.
What are the current challenges in clinical translation of hydrogel scaffolds for urethral repair?
Challenges include mechanical mismatch with the dynamic urethral environment, difficulty in precisely controlling degradation rates, and issues related to large-scale production consistency, sterility, long-term stability, and regulatory approval as combination products.
What are the future directions for hydrogel scaffold development in urethral tissue engineering?
Future directions include intelligent scaffolds that respond to the urethral microenvironment, engineered composites with decellularized extracellular matrix, and cell-free strategies such as exosome-loaded hydrogels to avoid risks associated with live cell transplantation.
How are hydrogel scaffolds prepared for urethral tissue engineering?
Common preparation methods include in situ gelation, freeze-drying, electrospinning, and 3D bioprinting. Crosslinking methods include physical and chemical crosslinking, which can be tailored to achieve desired mechanical and degradation properties.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.